title: Recommendations on the use of exercise testing in clinical practice.
abstract: Evidence-based recommendations on the clinical use of cardiopulmonary exercise testing (CPET) in lung and heart disease are presented, with reference to the assessment of exercise intolerance, prognostic assessment and the evaluation of therapeutic interventions (e.g. drugs, supplemental oxygen, exercise training). A commonly used grading system for recommendations in evidence-based guidelines was applied, with the grade of recommendation ranging from A, the highest, to D, the lowest. For symptom-limited incremental exercise, CPET indices, such as peak O(2) uptake (V'O(2)), V'O(2) at lactate threshold, the slope of the ventilation-CO(2) output relationship and the presence of arterial O(2) desaturation, have all been shown to have power in prognostic evaluation. In addition, for assessment of interventions, the tolerable duration of symptom-limited high-intensity constant-load exercise often provides greater sensitivity to discriminate change than the classical incremental test. Field-testing paradigms (e.g. timed and shuttle walking tests) also prove valuable. In turn, these considerations allow the resolution of practical questions that often confront the clinician, such as: 1) "When should an evaluation of exercise intolerance be sought?"; 2) "Which particular form of test should be asked for?"; and 3) "What cluster of variables should be selected when evaluating prognosis for a particular disease or the effect of a particular intervention?"
authors.affiliation: Servizio di Fisiopatologia Respiratoria, Dipartimento di Medicina Clinica, University of Rome "La Sapienza", Rome, Italy. paolo.palange@uniroma1.it
authors.forename: P
authors.initials: P
authors.lastname: Palange
authors.forename: S A
authors.initials: SA
authors.lastname: Ward
authors.forename: K-H
authors.initials: KH
authors.lastname: Carlsen
authors.forename: R
authors.initials: R
authors.lastname: Casaburi
authors.forename: C G
authors.initials: CG
authors.lastname: Gallagher
authors.forename: R
authors.initials: R
authors.lastname: Gosselink
authors.forename: D E
authors.initials: DE
authors.lastname: O'Donnell
authors.forename: L
authors.initials: L
authors.lastname: Puente-Maestu
authors.forename: A M
authors.initials: AM
authors.lastname: Schols
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: B J
authors.initials: BJ
authors.lastname: Whipp
mesh_terms: D005080:Exercise Test; D017079:Exercise Tolerance / Q000502:physiology; D006331:Heart Diseases / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis* / Q000503:physiopathology; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D011379:Prognosis